Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Insurance coverage can be more challenging than semaglutide
Many people continue with treatment despite initially feeling anxious or uncomfortable about injections
Tirzepatide targets multiple pathways involved in appetite regulation and glucose metabolism, leading to reduced food intake, weight loss, and improved glycemic control
However, GLP-1RAs should be considered as the preferential add-on therapy in T2DM patients with CKD in case of persistent albuminuria and/or uncontrolled metabolic risks (i.e., inadequate glycemic control, hypertension, overweight/obesity)
US$ 24.05
US$ 20.98
US$ 25.17
